Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
A New Treatment for CMT1A
…updates on CMT research and clinical trials such as this one, please complete a Patients as Partners in Research profile and support the CMTA’s mission to develop treatments for CMT….
Gifts of Stock
The CMTA is strongly committed to client services and to funding research and finding a cure. Gifts to client services make the day-to-day function of the CMTA possible, enabling us…
Welcome Back! We’ve Missed You!
WELCOME BACK! WE’VE MISSED YOU! Inside this Special Research Edition of the Spring 2021 CMTA Report, we bring you coverage of every aspect of CMTA-STAR from cross-type initiatives to our…
From Gene Discovery to Gene Editing: Closing the Diagnostic Gap and Developing CRISPR/Cas9 Capabilities in CMT
…with the Inherited Neuropathies Consortium (INC), researchers at the University of Miami, led by CMTA Strategy To Accelerate Research (STAR) Board member Stephan Zuchner, MD, PhD, are working to solve…
CMTA Announces New Center of Excellence in Thailand
…receiving her training from leading CMT specialist Michael Shy, MD, at the University of Iowa, she became interested in clinical research with children living with CMT. Her recent research includes…
Type 2 Update: One Patient’s Diagnostic Odyssey with SORD
…scholar from University College of London— discovered the SORD mutation “hidden” from the gene analysis software that most researchers use. Using a different strategy, the researchers found the relevant variations…
2021 STAR Accomplishments
With our community’s help, the CMTA has invested over $17.5 million in CMTA-STAR research since 2008, making us the largest charitable funder of CMT research globally. Through the support of…
CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
…largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with pharmaceutical and biotechnology…
Giant Axonal Neuropathy (GAN)
…removed and examined to look for swollen axons). A definitive diagnosis using genetic testing is available on a research basis only. What research is being done around GAN? Charcot-Marie-Tooth Association,…
CMTA Partnering is Open for Business
The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA team will be attending the PNS annual meeting in Copenhagen and have availability…